The Department of Government Efficiency initiative has put Dogecoin back in the spotlight. Find out why that might not be enough to push it to new highs this year.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Sterling (NASDAQSTRL) and the best and worst performers in the engineering and design services industry.
Shareholders of RXO would probably like to forget the past six months even happened. The stock dropped 28.1% and now trades at $20.27. This might have investors contemplating their next move.
Looking back on education services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Adtalem (NYSEATGE) and its peers.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the branded pharmaceuticals industry, including Corcept (NASDAQCORT) and its peers.
Over the past six months, Premier’s shares (currently trading at $17.93) have posted a disappointing 13.5% loss, well below the S&P 500’s 6.2% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Sabre (NASDAQSABR) and the rest of the travel and vacation providers stocks fared in Q4.
Himax has been on fire lately. In the past six months alone, the company’s stock price has rocketed 67.4%, reaching $9.29 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at hvac and water systems stocks, starting with Trane Technologies (NYSETT).
What a brutal six months it’s been for Dave & Buster's. The stock has dropped 36% and now trades at $19.30, rattling many shareholders. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the inspection instruments industry, including Keysight (NYSEKEYS) and its peers.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how AutoZone (NYSEAZO) and the rest of the auto parts retailer stocks fared in Q4.
Looking back on professional tools and equipment stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Nordson (NASDAQNDSN) and its peers.
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at UnitedHealth (NYSEUNH) and its peers.
G-III trades at $26.65 and has moved in lockstep with the market. Its shares have returned 6.4% over the last six months while the S&P 500 has gained 6.2%.
Over the past six months, Sirius XM’s stock price fell to $23.99. Shareholders have lost 18.1% of their capital, which is disappointing considering the S&P 500 has climbed by 6.2%. This may have investors wondering how to approach the situation.
Since September 2024, ResMed has been in a holding pattern, posting a small loss of 4.8% while floating around $233.10. The stock also fell short of the S&P 500’s 6.2% gain during that period.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, including Sarepta Therapeutics (NASDAQSRPT) and its peers.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Bristol-Myers Squibb (NYSEBMY) and the best and worst performers in the branded pharmaceuticals industry.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the online retail industry, including Wayfair (NYSEW) and its peers.
Let’s dig into the relative performance of Constellation Brands (NYSESTZ) and its peers as we unravel the now-completed Q4 beverages, alcohol, and tobacco earnings season.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Tennant (NYSETNC) and the rest of the water infrastructure stocks fared in Q4.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Danaher (NYSEDHR) and the best and worst performers in the research tools & consumables industry.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the content delivery industry, including Akamai (NASDAQAKAM) and its peers.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Henry Schein (NASDAQHSIC) and the best and worst performers in the dental equipment & technology industry.
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the building materials stocks, including Sherwin-Williams (NYSESHW) and its peers.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the home builders industry, including Lennar (NYSELEN) and its peers.
Looking back on data infrastructure stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Confluent (NASDAQCFLT) and its peers.
Morgan Stanley has reinstated Elon Musk's Tesla Inc. (NASDAQTSLA) as its top U.S. auto pick, citing the company's focus on artificial intelligence and robotics, in a note on Sunday.
